Antisense Therapeutics’ strategy is:
  • To create antisense drugs for diseases where there are large and/or poorly met markets, in collaboration with Antisense Therapeutics’ technology and research partners

  •  To advance these drugs successfully through pre-clinical and clnical development via out-sourcing arrangements with expert contractors
  • To commercialise the drugs that are shown to be successful in clinical testing by entering into licensing deals or other partnerships with major pharmaceutical companies.